Scanfil achieved Science Based Targets initiative’s approval
Scanfil Oyj has achieved the Science Based Targets initiative (SBTi) approval for its climate targets. This highlights the company's commitment to environmental responsibility and climate action. Targets include a significant reduction in greenhouse gas emissions by 2030. "Our ambitions demonstrate our leadership in environmental issues," says Christophe Sut, CEO.

Scanfil plc Press release 12 September 2024 at 9.00 a.m. EEST
Scanfil achieved Science Based Targets initiative’s approval
Scanfil, a leading provider of advanced electronics manufacturing services, is proud to announce the approval of its near-term science-based targets by the Science Based Targets initiative (SBTi). This significant achievement underscores Scanfil’s commitment to sustainability and climate action.
The SBTi has validated that Scanfil’s greenhouse gas (GHG) emissions reduction targets align with the latest climate science and are consistent with the goals of the Paris Agreement. Specifically, Scanfil commits to:
- Reduce absolute scope 1 and 2 GHG emissions by 55.8% by 2030 from a 2020 base year. Scope 3 inventory was not reported for that year.
- Reduce absolute scope 3 GHG emissions from purchased goods and services, capital goods, fuel- and energy-related activities, upstream transportation and distribution, waste generated in operations, business travel, and employee commuting by 25% by 2030 from a 2022 base year.
“These ambitious targets reflect Scanfil’s dedication to driving meaningful change and contributing to a sustainable future. By setting and achieving these goals, Scanfil not only demonstrates leadership in environmental stewardship but also inspires other organizations to take bold steps towards reducing their carbon footprint”, says CEO Christophe Sut.
SBTi’s Target Validation Report highlights Scanfil’s comprehensive approach to GHG emissions management. In 2020, Scanfil reported a total of 16,901 tCO2e for scope 1 and 2 emissions. By 2022, the company reported 955,102 tCO2e across scopes 1, 2, and 3, with a significant portion (65.22%) attributed to purchased goods and services. The report confirms that Scanfil’s targets meet the SBTi’s stringent criteria and are aligned with a 1.5°C trajectory.
“We are thrilled to receive this validation,” says Mats Lindblad Director of Quality and Sustainability at Scanfil. “SBTi’s approval is a testament to our team’s hard work and our commitment to making a positive impact on the environment. We believe that by taking decisive action today, we can help create a better tomorrow for future generations.”
Scanfil’s sustainability journey is a continuous one, and the company remains dedicated to exploring innovative solutions and partnerships that will further enhance its environmental performance.
For additional information:
Mats Lindblad
Director of Quality and Sustainability
Tel. ++46 73 807 13 09
Email mats.lindblad@scanfil.com
About Scanfil
Scanfil plc is the largest European stock-listed Electronics Manufacturing Service company (EMS) with EUR 902 million turnover in 2023. It serves global industry leaders in Industrial, Energy & Cleantech as well as the Medtech & Life Science customer segments. The service portfolio includes design services, prototyping, design for manufacturing (DFM), test development, supply chain and logistics services, PCBA, box-build manufacturing, and complex system integration services. Scanfil’s objective is to increase customer value by helping them become more competitive and be their global, most preferred supply chain, and long-term manufacturing partner. Scanfil’s longest customer relationship has lasted over three decades. It has nine production sites on three continents with global delivery capability. www.scanfil.com
Images
Alternative languages
Subscribe to releases from Scanfil Oyj
Subscribe to all the latest releases from Scanfil Oyj by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Scanfil Oyj
Scanfil och Etteplan fördjupar sitt strategiska partnerskap till produktionstester2.7.2025 09:00:00 EEST | Pressmeddelande
Scanfil och Etteplan har ingått ett serviceavtal för att förstärka sitt partnerskap inom produktionstestutveckling. Etteplan kommer att stötta Scanfil i utvecklingen av Odins testplattform och de planerar erbjuda gemensamma testprojekt till kunder. Detta strategiska samarbete förväntas sänka kunders investeringskostnader och påskynda tiden till marknad.
Scanfil ja Etteplan syventävät strategista kumppanuuttaan tuotannon testaukseen2.7.2025 09:00:00 EEST | Tiedote
Scanfil ja Etteplan laajentavat strategista kumppanuuttaan tuotannon testausjärjestelmäkehityksessä uudella palvelusopimuksella. Etteplan tukee Scanfilia Odin-testialustan kehittämisessä, ja yritykset suunnittelevat tarjoavansa asiakkailleen yhteisiä testisovellusprojekteja. Strategisen yhteistyön odotetaan alentavan asiakkaiden investointikustannuksia ja nopeuttavan markkinoille pääsyä.
Scanfil and Etteplan deepen their strategic partnership into production testing2.7.2025 09:00:00 EEST | Press release
Scanfil and Etteplan expand their strategic partnership in production testing with a new service agreement. Etteplan supports Scanfil in the development of the Odin test platform, and the companies plan to provide customers with joint test application projects. This strategic cooperation is expected to lower customers' investment costs and accelerate market access.
Scanfil stärker sin kundportfölj inom Medtech & Life Science genom att underteckna avtal med Liquid Instruments26.6.2025 08:00:00 EEST | Pressmeddelande
Scanfil har tecknat ett avtal om outsourcing med Liquid Instruments, vilket stärker Medtech & Life Sciences kundportfölj. Avtalet om outsourcing stöder produktionen av Liquid Instruments Moku-lösning i Australien. Produktionen kommer att äga rum på Scanfil's Melbourne fabrik, stärka inhemska leveranskedjor och expandera verksamheten i Australien. Strategiskt partnerskap förbättrar produktions- och försörjningskedjans styrning.
Scanfil vahvistaa Medtech & Life Science -asiakasportfoliotaan solmimalla yhteistyösopimuksen Liquid Instrumentsin kanssa26.6.2025 08:00:00 EEST | Tiedote
Scanfil solmi yhteistyösopimuksen Liquid Instrumentsin kanssa ja vahvistaa Medtech & Life Science -asiakasportfoliotaan. Ulkoistussopimus tukee Liquid Instrumentsin Moku-ratkaisun tuotantoa Australiassa. Tuotanto tapahtuu Scanfilin Melbournen tehtaalla, mikä vahvistaa maan sisäisiä toimitusketjuja ja laajentaa toimintaa Australiassa. Strateginen kumppanuus tehostaa tuotantoa ja toimitusketjun hallintaa.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom